{"id":298572,"date":"2019-10-16T23:00:17","date_gmt":"2019-10-17T06:00:17","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/10\/dmed-biopharma-a-china-us-eu-clinica\/"},"modified":"2019-10-16T23:13:33","modified_gmt":"2019-10-17T06:13:33","slug":"%e4%b8%ad%e7%be%8e%e7%bc%94%e8%84%89%e7%ad%b9%e8%b5%845000%e4%b8%87","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2019\/10\/%e4%b8%ad%e7%be%8e%e7%bc%94%e8%84%89%e7%ad%b9%e8%b5%845000%e4%b8%87\/","title":{"rendered":"\u4e2d\u7f8e\u7f14\u8109\u7b79\u8d44$5000\u4e07"},"content":{"rendered":"<p>\u7f14\u8109\u662f\u4e00\u5bb6\u5728\u4e2d\u56fd\u3001\u7f8e\u56fd\u548c\u6b27\u76df\u63d0\u4f9b\u4e34\u5e8a\u8bd5\u9a8c\u670d\u52a1\u7684CRO(\u533b\u836f\u7814\u53d1\u5408\u540c\u5916\u5305\u670d\u52a1\u673a\u6784)\uff0c\u8be5\u516c\u53f8\u5b8c\u6210\u4e86\u8fd1$5000\u4e07\u7684B\u8f6e\u878d\u8d44\uff0c\u8be5\u8f6e\u878d\u8d44\u7531\u7ef4\u68a7\u8d44\u672c\u9886\u6295\u3001\u541b\u8054\u8d44\u672c\u3001\u542f\u660e\u521b\u6295\u3001\u793c\u6765\u4e9a\u6d32\u57fa\u91d1\u53c2\u6295\u3002\u7f14\u8109\u6210\u7acb\u4e8e\u4e09\u5e74\u524d\uff0c\u81ea\u8ba4\u4e3a\u662f\u201c\u4e0b\u4e00\u4ee3\u201d\u4e34\u5e8aCRO\uff0c\u5177\u6709\u9ad8\u6548\u7684\u8fd0\u8425\u3001IT\u670d\u52a1\u548c\u8de8\u5883\u5168\u7403\u8bd5\u9a8c\u65b9\u9762\u7684\u4e13\u4e1a\u77e5\u8bc6\u3002 \u7f14\u8109\u6709600\u540d\u5458\u5de5\u3002 \u6700\u8fd1\uff0c\u7f14\u8109\u6536\u8d2d\u4e86\u4f4d\u4e8e\u7ebd\u7ea6\u7684\u5168\u65b9\u4f4d\u670d\u52a1CRO\u2014\u2014Target Health\uff0c\u4ee5\u6269\u5c55\u5176\u5168\u7403\u4e1a\u52a1\u5e76\u6dfb\u52a0\u65b0\u6280\u672f\u3002<\/p>\n<p>\u82f1\u6587\u6765\u6e90\uff1aChina Biotoday<\/p>\n","protected":false},"excerpt":{"rendered":"<p>dMed Biopharma, a Shanghai CRO that offers clinical trial services in China, the US and the EU, completed a Series B financing of nearly $50 million, led by Vivo Capital and joined by Legend Capital, Qiming Venture Partners and Lilly Asia Ventures. Launched three years ago, dMed considers itself a &#8220;next-gen&#8221; clinical CRO with efficient operations, IT services and expertise in cross-border global trials. The company has 600 employees. Recently, dMed acquired Target Health, a full service New York-based CRO, to expand its global offerings and add new technologies.\u00a0<\/p>\n","protected":false},"author":9,"featured_media":298558,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[455,925,459],"class_list":["post-298572","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-455","tag-925","tag-459","sectors-life-science-zh-hans","locations-china-zh-hans","locations-us-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/298572","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=298572"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/298572\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/298558"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=298572"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=298572"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=298572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}